Current NDC auxiliary source row compounder:757

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71285-0407
Product Ndc: 71285-0407
Product Ndc Digits: 712850407
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag
Proprietary Name Suffix: [empty]
Nonproprietary Name: Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag
Dosage Form Name: SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Central Admixture Pharmacy Services, Inc.
Establishment Name: Central Admixture Pharmacy Services, Inc.
Establishment Fei: [empty]
Substance Name: N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; LYSINE ACETATE; SERINE; TYROSINE
Active Ingredients Info: .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL
History Active Ingredients Raw: N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; LYSINE ACETATE; SERINE; TYROSINE
History Active Ingredients Info Raw: .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71285-0407-1
Package Ndc: 71285-0407-1
Package Ndc Digits: 7128504071
Package Ndc11: 71285040701
Package Description: 250 mL in 1 BAG (71285-0407-1)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:757
Source Row Number: 757
Source Row Hash: eb8bf0279f64405947970430245844bccd7797e9d233e3fb21cdaf95a35b0d09
Import Run Id: 20261017T224343Z
Loaded At: 2026-10-17 22:48:57

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71285-0407",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; LYSINE ACETATE; SERINE; TYROSINE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0407-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag",
    "PACKAGEDESCRIPTION": "250 mL in 1 BAG (71285-0407-1) ",
    "ACTIVEINGREDIENTSINFO": ".21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:757
Source Row Number: 757
Status Scope: package
Lookup Ndc: 71285-0407-1
Lookup Ndc Digits: 7128504071
Product Ndc: 71285-0407
Product Ndc Digits: 712850407
Package Ndc: 71285-0407-1
Package Ndc Digits: 7128504071
Package Ndc11: 71285040701
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: eb8bf0279f64405947970430245844bccd7797e9d233e3fb21cdaf95a35b0d09
Import Run Id: 20261017T224343Z
Loaded At: 2026-10-17 22:48:57